NG

Nitu Gupta

Active Director Director DIN 09797461
DIN 09797461 First appointment Nov 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2022
Shareholding value Locked Premium profile

About Nitu Gupta

Nitu Gupta has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Curezone Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09797461
Primary Designation Director
First Appointment 21 Nov 2022
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Curezone Pharma Private Limited U24290HR2022PTC107861
Director 21 Nov 2022 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Curezone Pharma Private Limited
Premium access

Shareholding and investment profile for Nitu Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitu Gupta

Nitu Gupta has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Curezone Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Nitu Gupta is associated with 1 company as Director.

Nitu Gupta has expertise in General Business.

Nitu Gupta has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available